FierceBiotechOriginal article
{"a":[{"_":"Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters","$":{"href":"/pharma/novartis-shareholder-calls-board-overhaul-following-costly-deal-setbacks-reuters","hreflang":"en"}}]}
Negative
AI Analysis
Summary
A major Novartis shareholder is calling for a board overhaul following recent clinical setbacks and costly failed deals. The shareholder has raised concerns about the board's oversight of the company's dealmaking activities.
Importance:5/10
Sentiment:
-0.60
clinical setbackboard oversightshareholder activismdeal failuregovernance
Related Companies
Read the original article
Published by FierceBiotech on September 10, 2026 10:09 AM
